TIAA FSB’s AbbVie ABBV Stock Holding History

TIAA FSB’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$31.3M	Sell	232,061 -2,125	-0.9%	-$312K	0.11%	95
2023 Q1	$37.3M	Sell	234,186 -41,922	-15%	-$6.41M	0.14%	83
2022 Q4	$44.6M	Sell	276,108 -13,295	-5%	-$2.04M	0.18%	75
2022 Q3	$38.8M	Sell	289,403 -52,696	-15%	-$7.56M	0.17%	73
2022 Q2	$52.4M	Sell	342,099 -14,699	-4%	-$2.25M	0.21%	64
2022 Q1	$57.7M	Sell	356,798 -60,438	-14%	-$8.78M	0.2%	60
2021 Q4	$56.3M	Sell	417,236 -1,584	-0.4%	-$187K	0.19%	60
2021 Q3	$45.2M	Buy	418,820 +3,940	+0.9%	+$450K	0.16%	70
2021 Q2	$46.7M	Buy	414,880 +2,068	+0.5%	+$233K	0.16%	66
2021 Q1	$44.7M	Sell	412,812 -43,781	-10%	-$4.68M	0.16%	66
2020 Q4	$48.9M	Sell	456,593 -929	-0.2%	-$89.3K	0.18%	61
2020 Q3	$40.1M	Buy	457,522 +49,482	+12%	+$4.66M	0.18%	65
2020 Q2	$40.1M	Buy	408,040 +25,486	+7%	+$2.24M	0.19%	62
2020 Q1	$29.1M	Buy	382,554 +25,299	+7%	+$2.15M	0.17%	62
2019 Q4	$31.6M	Sell	357,255 -29,964	-8%	-$2.49M	0.15%	67
2019 Q3	$29.3M	Buy	387,219 +218,230	+129%	+$15M	0.15%	65
2019 Q2	$12.3M	Sell	168,989 -2,914	-2%	-$229K	0.07%	103
2019 Q1	$13.9M	Buy	171,903 +361	+0.2%	+$29.5K	0.11%	95
2018 Q4	$15.8M	Sell	171,542 -2,186	-1%	-$192K	0.09%	80
2018 Q3	$16.4M	Sell	173,728 -12,156	-7%	-$1.15M	0.09%	84
2018 Q2	$17.2M	Sell	185,884 -57,278	-24%	-$5.59M	0.1%	73
2018 Q1	$23M	Sell	243,162 -74,189	-23%	-$8.15M	0.13%	62
2017 Q4	$30.7M	Buy	317,351 +11,851	+4%	+$1.12M	0.18%	51
2017 Q3	$27.1M	Sell	305,500 -26,768	-8%	-$2.04M	0.17%	53
2017 Q2	$24.1M	Buy	+332,268	New	+$22.3M	0.16%	58

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TIAA FSB's ABBV Position: Q2 2023 in Review

TIAA FSB reduced its AbbVie (ABBV) stake by 0.91% in Q2 2023, selling an estimated $312K and leaving 232,061 shares worth $31.3M. The position accounts for 0.11% of the portfolio, ranked #95.

TIAA FSB first reported a position in ABBV in Q2 2017 and has held it in 25 quarters since. The position peaked at $57.7M in Q1 2022. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

TIAA FSB held 232,061 shares of AbbVie worth $31.3M as of Q2 2023.
TIAA FSB sold 2,125 AbbVie shares in Q2 2023, an estimated $312K.
AbbVie made up 0.11% of TIAA FSB's portfolio in Q2 2023, its #95 holding.
TIAA FSB first reported a position in AbbVie in Q2 2017 and has held it in 25 quarters since.
TIAA FSB's AbbVie position peaked at $57.7M in Q1 2022.
3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.